were measured for their antibody activity using the two methods.
The correlation coefficient between these two methods was 0.68 (p<0.01). insulin in advance, the time necessary for the whole procedure was only 4hours at most.
Intra-and interassay variations
The results of intra-and interassay of two sera are shown in Table 2 . The coefficients of variation of intraassay in case 1 and 2 were 9.8% and 9.5% and those of In order to check the stability of the 125I-protein A method, sera obtained from two insulin-treated diabetics (case 1 and case 2) were measured ten times for their anti-insulin antibody activity in the same assay and CV values were calculated.
Reproduceability of 125I-protein A method was quantitated by CV values obtained by measuring the anti-insulin antibody activity by six different assays, respectively. the interassay were 9.5% and 9.2%, respectively.
Comparison of the present solid phase radioimmunoassay with the immune precipitation method Sera from 17 insulin-treated diabetics and 6 non-diabetic controls were measured simultaneously to determine their anti-insulin antibody activity using present solid phase radioimmunoassay and the immune precipitation method. The titer of anti-insulin antibodies as measured by 125I-protein A correlated well with percent binding (r= 0.68, p<0.01) obtained using the immune precipitation method (Gerbith and Kemmler, 1978) (Fig. 4) .
Discussion
Previously, one of the present authors (S. Sakata) reported a very sensitive radioimmunoassay for the detection of the autoantibodies to rabbit serum albumin in the rabbit immunized with the rabbit's own serum albumin, human serum albumin, or bovine serum albumin. In these experiments, 125I-protein A and 125I-goat anti-rabbit IgG were employed as a second antibody and we found 125I-protein A to be the better one (Sakata and Atassi, 1981) . This result led us to extend to other immunoassay systems for the detection of the antibodies. Anti-insulin antibodies were selected next, because of their clinical importance in the care of insulin-treated diabetic patients. As our present results indicate, this solid phase immunoassay worked well in the detection of anti-insulin antibodies.
Protein A is a protein isolated from the wall of the staphylococcus aureus. The characteristic property of protein A is it's ability to interact and to precipitate with a wide variety of IgG molecules from several species via the Fc part of the IgG molecule. Kronvall and Williams (1969) found that the precipitation reaction is specific for sub-class 1, 2 and 4 of human IgG. It has also been reported that IgA 2 binds to protein A while IgA 1 does not (Saltvedt and Harboe, 1976) . A minority of IgM is also reported to bind to protein A (Harboe and Folling. 1976) . Although anti-insulin antibody activity in sera has been demonstrated in all 5 major classes of immunoglobulins, most of the activity has been shown in the IgG class (Andersen, 1976) . IgG 3 accounts for only 1-3% of total human IgG, but may have anti-insulin activity. In addition, the presence of IgM class anti-insulin antibodies has been reported in insulin-treated patients, especially early in the course of insulin treatment and in patients with insulin resistance (Reisman et al, 1969) . Moreover, IgA (Kniker, 1967) , (Dolovich et al., 1970) class anti-insulin antibodies have been found in patients with insulin resistance and allergies. Such antiinsulin antibody activity might not be detected in this assay. Therefore, compared with other reported methods such as immune precipitation, our present method might have a disadvantage regarding the assayable immunoglobulins and their subclasses. However, in our examination of the sera from 17 insulin-treated diabetic patients, this was hardly a problem, for if high titers of anti-insulin immunoglobulins are present in other than IgG class, high percent binding of 125I-insulin and very low or negative radioactivity of the 125I-protein A could be expected in the same serum, but there wasn't such a case. 
